Clinical trial
TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation
NCT00145262 · Nagoya University, Other · Unknown status
Key facts
| NCT number | NCT00145262 |
|---|---|
| Title | TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation |
| Official title | Therapeutic Angiogenesis Using Cell Transplantation (TACT) Study at Nagoya |
| Lead sponsor | Nagoya University, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Buerger Disease, Arteriosclerosis Obliterans |
| Intervention type | Procedure |
| Interventions | Autologous Bone Marrow Mononuclear Cell Implantation |
| Start date | Aug 1, 2003 |
| First posted | Sep 5, 2005 |
| Last update posted | Dec 30, 2005 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: